Pharmacogenetics in Potential Herb-Drug Interactions: Effects of Ginseng on CYP3A4 and CYP2C9 Allelic Variants

被引：1

作者：

Luu, Alice ^{[1
]}

Foster, Brian C. ^{[1
]}

McIntyre, Kristina L. ^{[1
]}

Tam, Teresa W. ^{[1
]}

Arnason, John T. ^{[1
]}

机构：

[1] Therapeut Products Director Hlth Canada, Ottawa, ON, Canada

来源：

BIOLOGICAL ACTIVITY OF PHYTOCHEMICALS | 2011年 / 41卷

关键词：

POLYMORPHISMS; GINSENOSIDES; INHIBITION; WARFARIN; ENZYMES;

D O I：

10.1007/978-1-4419-7299-6_5

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：59 / +

页数：2

共 13 条

[1] Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications [J].

Aithal, GP ;

Day, CP ;

Kesteven, PJL ;

Daly, AK .

LANCET, 1999, 353 (9154) :717-719

[2] EVALUATION OF THE ERGOGENIC PROPERTIES OF GINSENG [J].

BAHRKE, MS ;

MORGAN, WP .

SPORTS MEDICINE, 1994, 18 (04) :229-248

[3] An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents [J].

Etheridge, Amy S. ;

Black, Sherry R. ;

Patel, Purvi R. ;

So, James ;

Mathews, James M. .

PLANTA MEDICA, 2007, 73 (08) :731-741

[4] Structure-Activity Relationship and Substrate-Dependent Phenomena in Effects of Ginsenosides on Activities of Drug-Metabolizing P450 Enzymes [J].

Hao, Miao ;

Zhao, Yuqing ;

Chen, Peizhan ;

Huang, He ;

Liu, Hong ;

Jiang, Hualiang ;

Zhang, Ruiwen ;

Wang, Hui .

PLOS ONE, 2008, 3 (07)

[5]

He Nu, 2004, Am J Ther, V11, P206, DOI 10.1097/00045391-200405000-00009

[6] Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity [J].

Henderson, GL ;

Harkey, MR ;

Gershwin, ME ;

Hackman, RM ;

Stern, JS ;

Stresser, DM .

LIFE SCIENCES, 1999, 65 (15) :PL209-PL214

[7] Probable interaction between warfarin and ginseng [J].

Janetzky, K ;

Morreale, AP .

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (06) :692-693

[8] Clinical consequences of cytochrome P4502C9 polymorphisms [J].

Kirchheiner, J ;

Brockmöller, J .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (01) :1-16

[9] Ginsenoside metabolites, rather than naturally occurring ginsenosides, lead to inhibition of human cytochrome P450 enzymes [J].

Liu, Yong ;

Zhang, Jiang-Wei ;

Li, Wei ;

Ma, Hong ;

Sun, Jie ;

Deng, Mai-Cun ;

Yang, Ling .

TOXICOLOGICAL SCIENCES, 2006, 91 (02) :356-364

[10] PHENELZINE AND THE DREAM MACHINE - RAMBLINGS AND REFLECTIONS [J].

SHADER, RI ;

GREENBLATT, DJ .

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1985, 5 (02) :65-65

← 1 2 →